• linkedin
  • Increase Font
  • Sharebar

    Is Express Scripts ‘slamming’ pharmacy customers?


    Five pharmacies from four states have filed a class-action lawsuit against pharmacy benefit manager (PBM) Express Scripts for allegedly using confidential patient data to steer customers away from retail pharmacies and into mail order.

    Courtesy: Shutterstock/Feng YuThe lawsuit was filed this month in United States District Court Eastern District of Missouri. The plaintiffs are Trone Health Services and Reddish Pharmacy (Idaho), Jabos Pharmacy (Tennessee), Oak Tree Pharmacy (Oregon), and Amrut JAL (Indiana). The pharmacies estimate that as many as 50,000 pharmacies could eventually join the action.

    Editor’s Choice: Pharmacists allege CVS rigged training pay

    The pharmacies allege that Express Scripts improperly used customer information and prescription data to steer customers away from their brick-and-mortar pharmacies into the PBM’s mail-order business. Express Scripts has access to the patient data to verify eligibility and to collect insurance payments. Express Scripts manages more than 25% of the insured in the United States.

    David Whitrap, Express Scripts’ senior director of corporate communications, termed the lawsuit baseless and said the company would defend itself vigorously.

    The pharmacies accuse Express Scripts of “slamming”—switching some customers into its mail-order business without the consumer’s permission. The company is accused of using prescription data to identify the most-profitable Rxs and then targeting those customers.

    According to the complaint, after customers are switched to mail order, the pharmacies are notified that the prescription has been switched to mandatory mail order and that only Express Scripts will be authorized to fill refills.

    Mark Lowery, Editor
    Mark Lowery an Editor for Drug Topics magazine.


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available